The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Kite, a Gilead company
Consulting or Advisory Role - Bayer; Kite, a Gilead company; Novartis; Verastem
Speakers' Bureau - Bayer; Kite, a Gilead company
Research Funding - Celgene; Juno Therapeutics; Kite, a Gilead company; Novartis; Seagen
ZUMA-12: A phase 2 multicenter study of axicabtagene ciloleucel (axi-cel) as a first-line therapy in patients (pts) with high-risk large B-cell lymphoma (LBCL).
 
Sattva Swarup Neelapu
Honoraria - Bio Ascend; Dava Oncology; Medscape; Physicans' Education Resource
Consulting or Advisory Role - Celgene; Cell Medica; Gilead Sciences; Incyte; Kite, a Gilead company; Merck Sharp & Dohme; Novartis; Pfizer; Precision Biosciences; Unum Therapeutics
Research Funding - Acerta Pharma; Bristol-Myers Squibb; Celgene; Cellectis; Gilead Sciences; Karus Therapeutics; Kite, a Gilead company; Merck Sharp & Dohme; Pharmacyclics; poseida therapeutics; Unum Therapeutics
Travel, Accommodations, Expenses - Celgene; Chugai Pharma; Dava Oncology; Kite/Gilead; Medscape; Merck; Novartis; Pfizer; Physicans' Education Resource; Precision Biosciences; Unum Therapeutics
 
Julio C. Chavez
Consulting or Advisory Role - Bayer; Genentech; Kite/Gilead; Novartis
Speakers' Bureau - Genentech; Janssen; Kite/Gilead; Novartis
Research Funding - Merck
 
Yi Lin
No Relationships to Disclose
 
Javier Munoz
Consulting or Advisory Role - Alexion Pharmaceuticals; Bayer; Bristol-Myers Squibb; Celgene; Genentech; Gilead Sciences; Janssen; Juno Therapeutics; Kite, a Gilead company; Kyowa Hakko Kirin; Pfizer; Pharmacyclics; Seagen
Speakers' Bureau - AstraZeneca; Bayer; Gilead Sciences; Kite, a Gilead company; Pharmacyclics/Janssen
 
Chaitra Shankar Ujjani
No Relationships to Disclose
 
Peter Riedell
No Relationships to Disclose
 
Sven De Vos
Consulting or Advisory Role - Bayer; Verastem
 
Olalekan O. Oluwole
Consulting or Advisory Role - Bayer; Kite, a Gilead company; Pfizer; Spectrum Pharmaceuticals
Research Funding - Kite, a Gilead company
 
Natasha Kekre
Consulting or Advisory Role - Jazz Pharmaceuticals; Kite, a Gilead company; Pharmacyclics
Research Funding - Kite, a Gilead company; Novartis; Pharmacyclics
Travel, Accommodations, Expenses - Jazz Pharmaceuticals
 
Yin Yang
Employment - Kite, a Gilead company
 
Lovely Goyal
Employment - Kite, a Gilead company
 
Kate Backhouse
Employment - Kite, a Gilead company
Stock and Other Ownership Interests - Gilead Sciences
Travel, Accommodations, Expenses - Gilead Sciences; Kite, a Gilead company
 
Francesca Milletti
Employment - Kite, a Gilead company; Roche
Stock and Other Ownership Interests - Gilead Sciences; Roche
Research Funding - Gilead Sciences; Roche
Patents, Royalties, Other Intellectual Property - Roche
Travel, Accommodations, Expenses - Gilead Sciences; Roche
 
Jun Kawashima
Employment - Kite, a Gilead company
 
Alex Francisco Herrera
Consulting or Advisory Role - Bristol-Myers Squibb; Genentech/Roche; Kite, a Gilead company; Merck; Pharmacyclics
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Immune Design (Inst); Kite, a Gilead company (Inst); Merck (Inst); Pharmacyclics (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb